Personal information

Emails & domains

Verified email domains

Other IDs

SciProfiles: 2964578

Activities

Collapse all

Works (6)

Treatment Strategies for Glioblastoma in the Elderly: What Should We Focus on Compared to Younger Patients

Cancers
2024-03-21 | Journal article
DOI: 10.3390/cancers16061231
Contributors: Hanah Hadice Gull; Antonia Carlotta Von Riegen; Greta Theresa Beckmann; Pikria Ketelauri; Sebastian Walbrodt; Alejandro N. Santos; Christoph Oster; Teresa Schmidt; Martin Glas; Ramazan Jabbarli et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Brainstem Infarction in Immunodeficiency Identified as Adenosine Deaminase 2 Deficiency: Case Report

Journal of Clinical Immunology
2023-10 | Journal article
DOI: 10.1007/s10875-023-01526-3
Contributors: Christoph Oster; Benjamin Stolte; Livia Asan; Refik Pul; Stephan Klebe; Martin Köhrmann; Katharina Breuckmann; Christoph Rischpler; Cornelius Deuschl; Sebastian Dolff et al.
Source: check_circle
Crossref

Telemedicine in Neuro-Oncology—An Evaluation of Remote Consultations during the COVID-19 Pandemic

Cancers
2023-08-11 | Journal article
DOI: 10.3390/cancers15164054
Contributors: Jonas Feldheim; Teresa Schmidt; Christoph Oster; Julia Feldheim; Martin Stuschke; Walter Stummer; Oliver Grauer; Björn Scheffler; Carsten Hagemann; Ulrich Sure et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

BRMS1 in Gliomas—An Expression Analysis

Cancers
2023-05-25 | Journal article
DOI: 10.3390/cancers15112907
Contributors: Jonas Feldheim; Almuth F. Kessler; Julia J. Feldheim; Dominik Schmitt; Christoph Oster; Lazaros Lazaridis; Martin Glas; Ralf-Ingo Ernestus; Camelia M. Monoranu; Mario Löhr et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Brainstem infarction in common variable immunodeficiency with adenosine deaminase 2 deficiency: case report

2023-02-14 | Preprint
DOI: 10.21203/rs.3.rs-2418177/v1
Contributors: Christoph Oster; Benjamin Stolte; Livia Asan; Refik Pul; Stephan Klebe; Martin Köhrmann; Katharina Breuckmann; Christoph Rischpler; Cornelius Deuschl; Christoph Kleinschnitz et al.
Source: check_circle
Crossref

Are we providing best-available care to newly diagnosed glioblastoma patients? Systematic review of phase III trials in newly diagnosed glioblastoma 2005–2022

Neuro-Oncology Advances
2023-01-01 | Journal article
DOI: 10.1093/noajnl/vdad105
Contributors: Christoph Oster; Teresa Schmidt; Sarina Agkatsev; Lazaros Lazaridis; Christoph Kleinschnitz; Ulrich Sure; Björn Scheffler; Sied Kebir; Martin Glas
Source: check_circle
Crossref

Peer review (3 reviews for 1 publication/grant)

Review activity for Neurosurgical review. (3)
How many people are using ORCID?